{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T00:51:34Z","timestamp":1789865494088,"version":"4.0.1"},"reference-count":141,"publisher":"Portland Press Ltd.","issue":"10","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,11,1]]},"abstract":"<jats:p>Neutrophil gelatinase-associated lipocalin (NGAL) has recently become established as an important contributor to the pathophysiology of cardiovascular disease. Accordingly, it is now viewed as an attractive candidate as a biomarker for various disease states, and in particular has recently become regarded as one of the best diagnostic biomarkers available for acute kidney injury. Nevertheless, the precise physiological effects of NGAL on the heart and the significance of their alterations during the development of heart failure are only now beginning to be characterized. Furthermore, the mechanisms via which NGAL mediates its effects are unclear because there is no conventional receptor signalling pathway. Instead, previous work suggests that regulation of iron metabolism could represent an important mechanism of NGAL action, with wide-ranging consequences spanning metabolic and cardiovascular diseases to host defence against bacterial infection. In the present review, we summarize rapidly emerging evidence for the role of NGAL in regulating heart failure. In particular, we focus on iron transport as a mechanism of NGAL action and discuss this in the context of the existing strong associations between iron overload and iron deficiency with cardiomyopathy.<\/jats:p>","DOI":"10.1042\/cs20150075","type":"journal-article","created":{"date-parts":[[2015,8,29]],"date-time":"2015-08-29T02:04:19Z","timestamp":1440813859000},"page":"851-862","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Iron metabolism and regulation by neutrophil gelatinase-associated lipocalin in cardiomyopathy"],"prefix":"10.1042","volume":"129","author":[{"given":"Yee\u00a0Kwan","family":"Chan","sequence":"first","affiliation":[{"name":"Department of Biology, York University, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye\u00a0Kyoung","family":"Sung","sequence":"additional","affiliation":[{"name":"Department of Biology, York University, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Sweeney","sequence":"additional","affiliation":[{"name":"Department of Biology, York University, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2015,8,28]]},"reference":[{"key":"2021113010371728400_B1","first-page":"164","article-title":"Review on iron and its importance for human health","volume":"19","author":"Abbaspour","year":"2014","journal-title":"J. Res. Med. Sci."},{"key":"2021113010371728400_B2","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nrn3453","article-title":"Iron metabolism in the CNS: implications for neurodegenerative diseases","volume":"14","author":"Rouault","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"2021113010371728400_B3","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1007\/s11883-013-0358-0","article-title":"Iron deficiency and cardiovascular disease: an updated review of the evidence","volume":"15","author":"Lapice","year":"2013","journal-title":"Curr. Atheroscler. Rep."},{"key":"2021113010371728400_B4","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nrc3495","article-title":"Iron and cancer: more ore to be mined","volume":"13","author":"Torti","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"2021113010371728400_B5","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1007\/s00198-012-1982-1","article-title":"Iron homeostasis in osteoporosis and its clinical implications","volume":"23","author":"Li","year":"2012","journal-title":"Osteoporos. Int."},{"key":"2021113010371728400_B6","doi-asserted-by":"publisher","first-page":"3730","DOI":"10.3390\/nu5093730","article-title":"Iron deficiency in heart failure: a practical guide","volume":"5","author":"Ebner","year":"2013","journal-title":"Nutrients"},{"key":"2021113010371728400_B7","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.jacc.2010.03.083","article-title":"Iron overload cardiomyopathy: better understanding of an increasing disorder","volume":"56","author":"Gujja","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"2021113010371728400_B8","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1093\/eurheartj\/ehs224","article-title":"Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives","volume":"34","author":"Jankowska","year":"2013","journal-title":"Eur. Heart J."},{"key":"2021113010371728400_B9","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1056\/NEJM199912233412607","article-title":"Disorders of iron metabolism","volume":"341","author":"Andrews","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"2021113010371728400_B10","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1042\/BJ20101825","article-title":"Regulation of cellular iron metabolism","volume":"434","author":"Wang","year":"2011","journal-title":"Biochem. J."},{"key":"2021113010371728400_B11","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1146\/annurev.nutr.26.061505.111303","article-title":"Regulation of iron metabolism by hepcidin","volume":"26","author":"Nemeth","year":"2006","journal-title":"Annu. Rev. Nutr."},{"key":"2021113010371728400_B12","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1016\/S0268-960X(08)70004-3","article-title":"Cardiac iron across different transfusion-dependent diseases","volume":"22","author":"Wood","year":"2008","journal-title":"Blood Rev."},{"key":"2021113010371728400_B13","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3109\/01480545.2012.726625","article-title":"Ferric iron uptake into cardiomyocytes of beta-thalassemic mice is not through calcium channels","volume":"36","author":"Kumfu","year":"2013","journal-title":"Drug Chem. Toxicol."},{"key":"2021113010371728400_B14","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1161\/01.RES.84.11.1302","article-title":"Modulation of iron uptake in heart by L-type Ca2+ channel modifiers: possible implications in iron overload","volume":"84","author":"Tsushima","year":"1999","journal-title":"Circ. Res."},{"key":"2021113010371728400_B15","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.3324\/haematol.2012.072314","article-title":"ZIP14 and DMT1\u00a0in the liver, pancreas, and heart are differentially regulated by iron deficiency and overload: implications for tissue iron uptake in iron-related disorders","volume":"98","author":"Nam","year":"2013","journal-title":"Haematologica"},{"key":"2021113010371728400_B16","doi-asserted-by":"publisher","first-page":"4808","DOI":"10.1074\/jbc.M111.275719","article-title":"Lipocalin-2 induces cardiomyocyte apoptosis by increasing intracellular iron accumulation","volume":"287","author":"Xu","year":"2012","journal-title":"J. Biol. Chem."},{"key":"2021113010371728400_B17","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.jnutbio.2008.07.014","article-title":"The iron regulatory hormone hepcidin reduces ferroportin 1 content and iron release in H9C2 cardiomyocytes","volume":"20","author":"Ge","year":"2009","journal-title":"J. Nutr. Biochem."},{"key":"2021113010371728400_B18","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/eurheartj\/ehq426","article-title":"Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment","volume":"32","author":"Borlaug","year":"2011","journal-title":"Eur. Heart J."},{"key":"2021113010371728400_B19","doi-asserted-by":"publisher","first-page":"4652","DOI":"10.1016\/j.ijcard.2013.07.185","article-title":"Functional iron deficiency and diastolic function in heart failure with preserved ejection fraction","volume":"168","author":"Kasner","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"2021113010371728400_B20","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","article-title":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC","volume":"33","author":"McMurray","year":"2012","journal-title":"Eur. Heart J."},{"key":"2021113010371728400_B21","doi-asserted-by":"publisher","first-page":"522","DOI":"10.7326\/0003-4819-143-7-200510040-00011","article-title":"Screening primary care patients for hereditary hemochromatosis with transferrin saturation and serum ferritin level: systematic review for the American College of Physicians","volume":"143","author":"Schmitt","year":"2005","journal-title":"Ann. Intern. Med."},{"key":"2021113010371728400_B22","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/BF00877096","article-title":"Iron overload cardiomyopathies: new insights into an old disease","volume":"8","author":"Liu","year":"1994","journal-title":"Cardiovasc. Drugs Ther."},{"key":"2021113010371728400_B23","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1136\/bmj.1.590.419","article-title":"Death from suffocation while inhaling chloroform: impaction of false teeth in larynx","volume":"1","author":"Chaffers","year":"1872","journal-title":"Br. Med. J."},{"key":"2021113010371728400_B24","first-page":"1739","article-title":"The dilated, restrictive, and infiltrative cardiomyopathies","volume-title":"In Braunwald's Heart Disease","author":"Hare","year":"2008"},{"key":"2021113010371728400_B25","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1016\/j.amjcard.2011.06.071","article-title":"Comparison of ascending aortic size in patients with severe bicuspid aortic valve stenosis treated with versus without a statin drug","volume":"108","author":"Goel","year":"2011","journal-title":"Am. J. Cardiol."},{"key":"2021113010371728400_B26","doi-asserted-by":"publisher","first-page":"e112915","DOI":"10.1371\/journal.pone.0112915","article-title":"Iron overload and apoptosis of HL-1 cardiomyocytes: effects of calcium channel blockade","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS One"},{"key":"2021113010371728400_B27","doi-asserted-by":"publisher","first-page":"269","DOI":"10.2174\/15672026113109990016","article-title":"Iron-induced fibrin in cardiovascular disease","volume":"10","author":"Lipinski","year":"2013","journal-title":"Curr. Neurovasc. Res."},{"key":"2021113010371728400_B28","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.bbagen.2008.06.005","article-title":"Iron in arterial plaque: modifiable risk factor for atherosclerosis","volume":"1790","author":"Sullivan","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"2021113010371728400_B29","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/BF02256112","article-title":"Dietary iron restriction increases plaque stability in apolipoprotein-e-deficient mice","volume":"10","author":"Lee","year":"2003","journal-title":"J. Biomed. Sci."},{"key":"2021113010371728400_B30","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1161\/01.CIR.99.9.1222","article-title":"Iron-deficient diet reduces atherosclerotic lesions in apoE-deficient mice","volume":"99","author":"Lee","year":"1999","journal-title":"Circulation"},{"key":"2021113010371728400_B31","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/j.freeradbiomed.2005.01.008","article-title":"The iron chelator desferrioxamine inhibits atherosclerotic lesion development and decreases lesion iron concentrations in the cholesterol-fed rabbit","volume":"38","author":"Minqin","year":"2005","journal-title":"Free Radic. Biol. Med."},{"key":"2021113010371728400_B32","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0014-5793(99)01199-0","article-title":"The onset of atherosclerotic lesion formation in hypercholesterolemic rabbits is delayed by iron depletion","volume":"459","author":"Ponraj","year":"1999","journal-title":"FEBS Lett."},{"key":"2021113010371728400_B33","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1161\/ATVBAHA.112.253088","article-title":"Ferritin is independently associated with the presence of coronary artery calcium in 12,033 men","volume":"32","author":"Sung","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2021113010371728400_B34","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1097\/HPC.0b013e3181eb64f5","article-title":"Serum ferritin is linked with aortic stiffness in apparently healthy Korean women","volume":"9","author":"Lee","year":"2010","journal-title":"Crit. Pathway Cardiol."},{"key":"2021113010371728400_B35","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/j.jvs.2009.12.068","article-title":"Ferritin levels, inflammatory biomarkers, and mortality in peripheral arterial disease: a substudy of the Iron (Fe) and Atherosclerosis Study (FeAST) Trial","volume":"51","author":"Depalma","year":"2010","journal-title":"J. Vasc. Surg."},{"key":"2021113010371728400_B36","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1161\/01.CIR.103.23.2799","article-title":"Iron chelation improves endothelial function in patients with coronary artery disease","volume":"103","author":"Duffy","year":"2001","journal-title":"Circulation"},{"key":"2021113010371728400_B37","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0021-9150(98)00070-7","article-title":"Lack of association between ferritin level and measures of LDL oxidation: the ARIC study. Atherosclerosis Risk in Communities","volume":"139","author":"Iribarren","year":"1998","journal-title":"Atherosclerosis"},{"key":"2021113010371728400_B38","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.diabet.2007.04.004","article-title":"Dietary iron intake and serum ferritin in relation to 7.5\u00a0years structure and function of large arteries in the SUVIMAX cohort","volume":"33","author":"Vergnaud","year":"2007","journal-title":"Diabetes Metab."},{"key":"2021113010371728400_B39","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s00277-010-1144-5","article-title":"Anemia\u2013still a major health problem in many parts of the world!","volume":"90","author":"Milman","year":"2011","journal-title":"Ann. Hematol."},{"key":"2021113010371728400_B40","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1136\/heartjnl-2014-305669","article-title":"Iron deficiency: an emerging therapeutic target in heart failure","volume":"100","author":"Cohen-Solal","year":"2014","journal-title":"Heart"},{"key":"2021113010371728400_B41","first-page":"115","article-title":"Word about a good medical journal","volume":"44","author":"Nestorowicz","year":"2012","journal-title":"Anaesthesiol. Intensive Ther."},{"key":"2021113010371728400_B42","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1620\/tjem.218.93","article-title":"Serum hepcidin-20 is elevated during the acute phase of myocardial infarction","volume":"218","author":"Suzuki","year":"2009","journal-title":"Tohoku J. Exp. Med."},{"key":"2021113010371728400_B43","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1093\/eurheartj\/ehq158","article-title":"Iron deficiency: an ominous sign in patients with systolic chronic heart failure","volume":"31","author":"Jankowska","year":"2010","journal-title":"Eur. Heart J."},{"key":"2021113010371728400_B44","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.jacc.2011.04.040","article-title":"Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival","volume":"58","author":"Okonko","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"2021113010371728400_B45","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.ahj.2013.01.017","article-title":"Iron deficiency in chronic heart failure: an international pooled analysis","volume":"165","author":"Klip","year":"2013","journal-title":"Am. Heart J."},{"key":"2021113010371728400_B46","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"2021113010371728400_B47","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.ahj.2012.05.026","article-title":"Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial)","volume":"164","author":"Mathiasen","year":"2012","journal-title":"Am. Heart J."},{"key":"2021113010371728400_B48","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jacc.2007.09.036","article-title":"Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial","volume":"51","author":"Okonko","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"2021113010371728400_B49","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1016\/j.ijcard.2013.04.181","article-title":"IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia","volume":"168","author":"Beck-da-Silva","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"2021113010371728400_B50","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.jacc.2008.04.061","article-title":"Anemia and mortality in heart failure patients a systematic review and meta-analysis","volume":"52","author":"Groenveld","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"2021113010371728400_B51","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1161\/01.CIR.0000134279.79571.73","article-title":"Anemia and its relationship to clinical outcome in heart failure","volume":"110","author":"Anand","year":"2004","journal-title":"Circulation"},{"key":"2021113010371728400_B52","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1161\/01.CIR.0000052622.51963.FC","article-title":"Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure","volume":"107","author":"Ezekowitz","year":"2003","journal-title":"Circulation"},{"key":"2021113010371728400_B53","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1161\/CIRCULATIONAHA.105.577577","article-title":"Hemoglobin level, chronic kidney disease, and the risks of death and hospitali-zation in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study","volume":"113","author":"Go","year":"2006","journal-title":"Circulation"},{"key":"2021113010371728400_B54","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/j.1751-7133.2008.00030.x","article-title":"The impact of anemia on the prognosis of chronic heart failure: a meta-analysis and systemic review","volume":"15","author":"He","year":"2009","journal-title":"Congest. Heart Fail."},{"key":"2021113010371728400_B55","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1001\/archinte.165.19.2237","article-title":"Anemia and outcomes in patients with heart failure: a study from the National Heart Care Project","volume":"165","author":"Kosiborod","year":"2005","journal-title":"Arch. Intern. Med."},{"key":"2021113010371728400_B56","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s11936-008-0038-5","article-title":"Anemia in heart failure: to treat or not to treat?","volume":"10","author":"Mak","year":"2008","journal-title":"Curr. Treat. Options Cardiovasc. Med."},{"key":"2021113010371728400_B57","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s10157-008-0074-1","article-title":"The correction of anemia in patients with the combination of chronic kidney disease and congestive heart failure may prevent progression of both conditions","volume":"13","author":"Silverberg","year":"2009","journal-title":"Clin. Exp. Nephrol."},{"key":"2021113010371728400_B58","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.amjcard.2007.07.067","article-title":"Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (insight from the OPTIMIZE-HF registry)","volume":"101","author":"Young","year":"2008","journal-title":"Am. J. Cardiol."},{"key":"2021113010371728400_B59","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/phar.1412","article-title":"Distinguishing anemia and iron deficiency of heart failure: signal for severity of disease or unmet therapeutic need?","volume":"34","author":"Beavers","year":"2014","journal-title":"Pharmacotherapy"},{"key":"2021113010371728400_B60","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1161\/CIRCULATIONAHA.107.698514","article-title":"Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia","volume":"117","author":"Ghali","year":"2008","journal-title":"Circulation"},{"key":"2021113010371728400_B61","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1053\/j.ajkd.2009.04.008","article-title":"Baseline characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)","volume":"54","author":"Pfeffer","year":"2009","journal-title":"Am. J. Kidney Dis."},{"key":"2021113010371728400_B62","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1097\/MNH.0b013e32833c3cc7","article-title":"Are there implications from the Trial to Reduce Cardiovascular Events with Aranesp Therapy study for anemia management in dialysis patients?","volume":"19","author":"Berns","year":"2010","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"2021113010371728400_B63","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.ahj.2011.07.016","article-title":"Predictors of fatal and nonfatal cardiovascular events in patients with type\u00a02 diabetes mellitus, chronic kidney disease, and anemia: an analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT)","volume":"162","author":"McMurray","year":"2011","journal-title":"Am. Heart J."},{"key":"2021113010371728400_B64","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1053\/j.ajkd.2012.08.043","article-title":"Hemoglobin stability in patients with anemia, CKD, and type\u00a02 diabetes: an analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) placebo arm","volume":"61","author":"Skali","year":"2013","journal-title":"Am. J. Kidney Dis."},{"key":"2021113010371728400_B65","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1053\/j.ajkd.2014.05.013","article-title":"Erythropoiesis-stimulating agent use among non-dialysis-dependent CKD patients before and after the trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT) using a large US health plan database","volume":"64","author":"Thamer","year":"2014","journal-title":"Am. J. Kidney Dis."},{"key":"2021113010371728400_B66","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2015.02.324","article-title":"Cause of death in patients with diabetic CKD enrolled in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)","author":"Charytan","year":"2015","journal-title":"Am. J. Kidney Dis."},{"key":"2021113010371728400_B67","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1093\/eurjhf\/hfp098","article-title":"Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a phase III, anaemia correction, morbidity\u2013mortality trial","volume":"11","author":"McMurray","year":"2009","journal-title":"Eur. J. Heart Fail."},{"key":"2021113010371728400_B68","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1093\/eurjhf\/hfs204","article-title":"Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF)","volume":"15","author":"McMurray","year":"2013","journal-title":"Eur. J. Heart Fail."},{"key":"2021113010371728400_B69","doi-asserted-by":"publisher","first-page":"426","DOI":"10.4103\/1658-354X.105899","article-title":"Can entropy predict neurologic complications after cardiac surgery?","volume":"6","author":"El Tahan","year":"2012","journal-title":"Saudi J. Anaesth."},{"key":"2021113010371728400_B70","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1179\/135100002125000596","article-title":"Iron and carcinogenesis: from Fenton reaction to target genes","volume":"7","author":"Toyokuni","year":"2002","journal-title":"Redox Rep."},{"key":"2021113010371728400_B71","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"2021113010371728400_B72","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0022-5223(19)35212-2","article-title":"Deferoxamine reduces neutrophil-mediated free radical production during cardiopulmonary bypass in man","volume":"96","author":"Menasche","year":"1988","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"2021113010371728400_B73","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s10557-006-0497-4","article-title":"Dexrazoxane prevents myocardial ischemia\/reperfusion-induced oxidative stress in the rat heart","volume":"20","author":"Ramu","year":"2006","journal-title":"Cardiovasc. Drugs Ther."},{"key":"2021113010371728400_B74","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.freeradbiomed.2004.10.015","article-title":"Deferoxamine induces prolonged cardiac preconditioning via accumulation of oxygen radicals","volume":"38","author":"Dendorfer","year":"2005","journal-title":"Free Radic. Biol Med."},{"key":"2021113010371728400_B75","first-page":"161","article-title":"Prospects for introducing deferiprone as potent pharmaceutical antioxidant","volume":"1","author":"Kontoghiorghes","year":"2009","journal-title":"Front. Biosci. (Elite Ed.)"},{"key":"2021113010371728400_B76","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00702-010-0503-7","article-title":"Iron-dependent functions of mitochondria\u2013relation to neurodegeneration","volume":"118","author":"Gille","year":"2011","journal-title":"J. Neural Transm."},{"key":"2021113010371728400_B77","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.bbagen.2008.09.008","article-title":"The role of iron in mitochondrial function","volume":"1790","author":"Levi","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"2021113010371728400_B78","doi-asserted-by":"publisher","first-page":"13047","DOI":"10.1073\/pnas.1109986108","article-title":"Facile transfer of [2Fe-2S] clusters from the diabetes drug target mitoNEET to an apo-acceptor protein","volume":"108","author":"Zuris","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021113010371728400_B79","doi-asserted-by":"publisher","first-page":"14342","DOI":"10.1073\/pnas.0707189104","article-title":"MitoNEET is a uniquely folded 2Fe 2S outer mitochondrial membrane protein stabilized by pioglitazone","volume":"104","author":"Paddock","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021113010371728400_B80","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1073\/pnas.1116369109","article-title":"Strand swapping regulates the iron-sulfur cluster in the diabetes drug target mitoNEET","volume":"109","author":"Baxter","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021113010371728400_B81","doi-asserted-by":"publisher","first-page":"5318","DOI":"10.1073\/pnas.0701078104","article-title":"MitoNEET is an iron-containing outer mitochondrial membrane protein that regulates oxidative capacity","volume":"104","author":"Wiley","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021113010371728400_B82","doi-asserted-by":"publisher","first-page":"23745","DOI":"10.1074\/jbc.C700107200","article-title":"The outer mitochondrial membrane protein mitoNEET contains a novel redox-active 2Fe-2S cluster","volume":"282","author":"Wiley","year":"2007","journal-title":"J. Biol. Chem."},{"key":"2021113010371728400_B83","doi-asserted-by":"publisher","first-page":"8318","DOI":"10.1074\/jbc.M705570200","article-title":"Cellular and mitochondrial remodeling upon defects in iron-sulfur protein biogenesis","volume":"283","author":"Hausmann","year":"2008","journal-title":"J. Biol. Chem."},{"key":"2021113010371728400_B84","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0092-8674(04)00343-5","article-title":"Balancing acts: molecular control of mammalian iron metabolism","volume":"117","author":"Hentze","year":"2004","journal-title":"Cell"},{"key":"2021113010371728400_B85","doi-asserted-by":"publisher","first-page":"E252","DOI":"10.1152\/ajpendo.00424.2003","article-title":"Identification of a novel mitochondrial protein (\u2018mitoNEET\u2019) cross-linked specifically by a thiazolidinedione photoprobe","volume":"286","author":"Colca","year":"2004","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"2021113010371728400_B86","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1038\/nm.2899","article-title":"MitoNEET-driven alterations in adipocyte mitochondrial activity reveal a crucial adaptive process that preserves insulin sensitivity in obesity","volume":"18","author":"Kusminski","year":"2012","journal-title":"Nat Med."},{"key":"2021113010371728400_B87","doi-asserted-by":"publisher","first-page":"8756","DOI":"10.1021\/bi1008613","article-title":"Molecular details of the yeast frataxin-Isu1 interaction during mitochondrial Fe-S cluster assembly","volume":"49","author":"Cook","year":"2010","journal-title":"Biochemistry"},{"key":"2021113010371728400_B88","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.jacc.2012.08.1021","article-title":"Mitochondria as a therapeutic target in heart failure","volume":"61","author":"Bayeva","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"2021113010371728400_B89","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.pharmthera.2013.07.005","article-title":"Mitochondrial inner membrane lipids and proteins as targets for decreasing cardiac ischemia\/reperfusion injury","volume":"140","author":"Brown","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"2021113010371728400_B90","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1111\/j.1742-4658.2007.05639.x","article-title":"ER stress and diseases","volume":"274","author":"Yoshida","year":"2007","journal-title":"FEBS J."},{"key":"2021113010371728400_B91","doi-asserted-by":"publisher","first-page":"H52","DOI":"10.1152\/ajpheart.01046.2005","article-title":"Targeted deletion of Puma attenuates cardiomyocyte death and improves cardiac function during ischemia-reperfusion","volume":"291","author":"Toth","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"2021113010371728400_B92","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1128\/MCB.00408-06","article-title":"Role of disulfide bridges formed in the luminal domain of ATF6\u00a0in sensing endoplasmic reticulum stress","volume":"27","author":"Nadanaka","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"2021113010371728400_B93","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1161\/01.CIR.0000137836.95625.D4","article-title":"Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis","volume":"110","author":"Okada","year":"2004","journal-title":"Circulation"},{"key":"2021113010371728400_B94","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1096\/fj.02-0644fje","article-title":"Overexpression of the stress protein Grp94 reduces cardiomyocyte necrosis due to calcium overload and simulated ischemia","volume":"17","author":"Vitadello","year":"2003","journal-title":"FASEB J."},{"key":"2021113010371728400_B95","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/j.1440-1681.2008.05114.x","article-title":"Endoplasmic reticulum stress involved in heart and liver injury in iron-loaded rats","volume":"36","author":"Lou","year":"2009","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"2021113010371728400_B96","doi-asserted-by":"publisher","first-page":"13161","DOI":"10.1074\/jbc.M110.170944","article-title":"Mutant HFE H63D protein is associated with prolonged endoplasmic reticulum stress and increased neuronal vulnerability","volume":"286","author":"Liu","year":"2011","journal-title":"J. Biol. Chem."},{"key":"2021113010371728400_B97","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/labinvest.2013.121","article-title":"Excess iron modulates endoplasmic reticulum stress-associated pathways in a mouse model of alcohol and high-fat diet-induced liver injury","volume":"93","author":"Tan","year":"2013","journal-title":"Lab. Invest."},{"key":"2021113010371728400_B98","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1126\/science.1176639","article-title":"ER stress controls iron metabolism through induction of hepcidin","volume":"325","author":"Vecchi","year":"2009","journal-title":"Science"},{"key":"2021113010371728400_B99","doi-asserted-by":"publisher","first-page":"e6618","DOI":"10.1371\/journal.pone.0006618","article-title":"ER stress-inducible factor CHOP affects the expression of hepcidin by modulating C\/EBPalpha activity","volume":"4","author":"Oliveira","year":"2009","journal-title":"PLoS One"},{"key":"2021113010371728400_B100","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1101\/gad.1599207","article-title":"Autophagy: process and function","volume":"21","author":"Mizushima","year":"2007","journal-title":"Genes Dev."},{"key":"2021113010371728400_B101","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nature09782","article-title":"Autophagy in immunity and inflammation","volume":"469","author":"Levine","year":"2011","journal-title":"Nature"},{"key":"2021113010371728400_B102","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1111\/bph.12477","article-title":"Autophagy and mitophagy in the myocardium: therapeutic potential and concerns","volume":"171","author":"Jimenez","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"2021113010371728400_B103","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1016\/j.cardfail.2009.06.306","article-title":"The role of autophagy in iron-overload cardiomyopathy: a model of diastolic heart failure due to oxidative stress","volume":"15","author":"Li","year":"2009","journal-title":"J. Card. Fail."},{"key":"2021113010371728400_B104","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nature13148","article-title":"Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy","volume":"509","author":"Mancias","year":"2014","journal-title":"Nature"},{"key":"2021113010371728400_B105","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.cardiores.2005.08.014","article-title":"Autophagy in cardiac myocyte homeostasis, aging, and pathology","volume":"68","author":"Terman","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"2021113010371728400_B106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3180001","article-title":"The lipocalin protein family: structure and function","volume":"318","author":"Flower","year":"1996","journal-title":"Biochem. J."},{"key":"2021113010371728400_B107","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0167-4838(00)00148-5","article-title":"The lipocalin protein family: structural and sequence overview","volume":"1482","author":"Flower","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"2021113010371728400_B108","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nature03104","article-title":"Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron","volume":"432","author":"Flo","year":"2004","journal-title":"Nature"},{"key":"2021113010371728400_B109","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S1097-2765(02)00708-6","article-title":"The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition","volume":"10","author":"Goetz","year":"2002","journal-title":"Mol. Cell"},{"key":"2021113010371728400_B110","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/hep.27447","article-title":"Liver is the major source of elevated serum lipocalin-2 levels after bacterial infection or partial hepatectomy: a critical role for IL-6\/STAT3","volume":"61","author":"Xu","year":"2015","journal-title":"Hepatology"},{"key":"2021113010371728400_B111","doi-asserted-by":"publisher","first-page":"e96997","DOI":"10.1371\/journal.pone.0096997","article-title":"Lipocalin 2 expression and secretion is highly regulated by metabolic stress, cytokines, and nutrients in adipocytes","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS One"},{"key":"2021113010371728400_B112","first-page":"920195","article-title":"The cardiorenal syndrome: a review","volume":"2011","author":"Shah","year":"2010","journal-title":"Int. J. Nephrol."},{"key":"2021113010371728400_B113","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1016\/j.jacc.2010.10.065","article-title":"Volume status and diuretic therapy in systolic heart failure and the detection of early abnormalities in renal and tubular function","volume":"57","author":"Damman","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"2021113010371728400_B114","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.1097\/01.ASN.0000145013.44578.45","article-title":"Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin","volume":"15","author":"Mishra","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"2021113010371728400_B115","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nrcardio.2012.37","article-title":"Novel biomarkers in chronic heart failure","volume":"9","author":"Ahmad","year":"2012","journal-title":"Nat. Rev. Cardiol."},{"key":"2021113010371728400_B116","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1093\/eurjhf\/hfr087","article-title":"Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: the NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial","volume":"13","author":"Maisel","year":"2011","journal-title":"Eur. J. Heart Fail."},{"key":"2021113010371728400_B117","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ijcard.2011.07.080","article-title":"Prognostic value of neutrophil gelatinase-associated lipocalin in acute heart failure","volume":"165","author":"Alvelos","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"2021113010371728400_B118","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.bbi.2013.12.023","article-title":"Neutrophil gelatinase-associated lipocalin and depression in patients with chronic heart failure","volume":"38","author":"Naude","year":"2014","journal-title":"Brain Behav. Immun."},{"key":"2021113010371728400_B119","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/j.1365-2796.2011.02503.x","article-title":"The association between neutrophil gelatinase-associated lipocalin and clinical outcome in chronic heart failure: results from CORONA","volume":"271","author":"Nymo","year":"2012","journal-title":"J. Intern. Med."},{"key":"2021113010371728400_B120","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1093\/eurheartj\/ehp088","article-title":"Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure","volume":"30","author":"Yndestad","year":"2009","journal-title":"Eur. Heart J."},{"key":"2021113010371728400_B121","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.healun.2014.06.007","article-title":"Neutrophil gelatinase-associated lipocalin and cystatin C for the prediction of clinical events in patients with advanced heart failure and after ventricular assist device placement","volume":"33","author":"Pronschinske","year":"2014","journal-title":"J. Heart Lung Transplant."},{"key":"2021113010371728400_B122","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1089\/rej.2008.0803","article-title":"Increased plasma neutrophil gelatinase-associated lipocalin levels predict mortality in elderly patients with chronic heart failure","volume":"12","author":"Bolignano","year":"2009","journal-title":"Rejuvenation Res."},{"key":"2021113010371728400_B123","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/CIRCHEARTFAILURE.113.000242","article-title":"Prognostic value of plasma neutrophil gelatinase-associated lipocalin for mortality in patients with heart failure","volume":"7","author":"van Deursen","year":"2014","journal-title":"Circ. Heart Fail."},{"key":"2021113010371728400_B124","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.jacc.2011.11.046","article-title":"Plasma neutrophil gelatinase-associated lipocalin is independently associated with cardiovascular disease and mortality in community-dwelling older adults: the Rancho Bernardo Study","volume":"59","author":"Daniels","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"2021113010371728400_B125","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.cell.2005.10.027","article-title":"A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake","volume":"123","author":"Devireddy","year":"2005","journal-title":"Cell"},{"key":"2021113010371728400_B126","doi-asserted-by":"publisher","first-page":"e1000949","DOI":"10.1371\/journal.ppat.1000949","article-title":"The battle for iron between bacterial pathogens and their vertebrate hosts","volume":"6","author":"Skaar","year":"2010","journal-title":"PLoS Pathog."},{"key":"2021113010371728400_B127","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.4049\/jimmunol.1200892","article-title":"Lipocalin 2 deficiency dysregulates iron homeostasis and exacerbates endotoxin-induced sepsis","volume":"189","author":"Srinivasan","year":"2012","journal-title":"J. Immunol."},{"key":"2021113010371728400_B128","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S1097-2765(02)00710-4","article-title":"An iron delivery pathway mediated by a lipocalin","volume":"10","author":"Yang","year":"2002","journal-title":"Mol. Cell"},{"key":"2021113010371728400_B129","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.1093\/ndt\/gfp310","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL) reflects iron status in haemodialysis patients","volume":"24","author":"Bolignano","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"key":"2021113010371728400_B130","first-page":"1036","article-title":"Neutrophil gelatinase associated lipocalin (NGAL) as a biomarker of iron deficiency in hemodialysis patients","volume":"2","author":"Ismail","year":"2015","journal-title":"Austin J. Nephrol. Hypertens."},{"key":"2021113010371728400_B131","doi-asserted-by":"publisher","first-page":"c268","DOI":"10.1159\/000313485","article-title":"Possible relationship between neutrophil gelatinase-associated lipocalin, hepcidin, and inflammation in haemodialysed patients","volume":"115","author":"Malyszko","year":"2010","journal-title":"Nephron Clin. Pract."},{"key":"2021113010371728400_B132","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/MPH.0b013e3182756dea","article-title":"Low serum lipocalin levels in patients with iron deficiency anemia","volume":"35","author":"Malbora","year":"2013","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"2021113010371728400_B133","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1159\/000343392","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL) in chronic cardiorenal failure is correlated with endogenous erythropoietin levels and decreases in response to low-dose erythropoietin treatment","volume":"36","author":"Emans","year":"2012","journal-title":"Kidney Blood Press. Res."},{"key":"2021113010371728400_B134","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1253\/circj.CJ-09-0485","article-title":"Lipocalin-2\/neutrophil gelatinase-B associated lipocalin is strongly induced in hearts of rats with autoimmune myocarditis and in human myocarditis","volume":"74","author":"Ding","year":"2010","journal-title":"Circ. J."},{"key":"2021113010371728400_B135","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1161\/ATVBAHA.114.303950","article-title":"Plasma neutrophil gelatinase-associated lipocalinin in the general population: association with inflammation and prognosis","volume":"34","author":"Lindberg","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2021113010371728400_B136","doi-asserted-by":"publisher","first-page":"5960","DOI":"10.1074\/jbc.M113.532234","article-title":"The induction of lipocalin-2 protein expression in\u00a0vivo and in\u00a0vitro","volume":"289","author":"Zhao","year":"2014","journal-title":"J. Biol. Chem."},{"key":"2021113010371728400_B137","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.2353\/ajpath.2006.050706","article-title":"Induction of neutrophil gelatinase-associated lipocalin in vascular injury via activation of nuclear factor-kappaB","volume":"169","author":"Bu","year":"2006","journal-title":"Am. J. Pathol."},{"key":"2021113010371728400_B138","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/sji.12245","article-title":"Lipocalin-2 promotes m1 macrophages polarization in a mouse cardiac ischaemia-reperfusion injury model","volume":"81","author":"Cheng","year":"2015","journal-title":"Scand. J. Immunol."},{"key":"2021113010371728400_B139","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.expneurol.2014.01.009","article-title":"The pivotal role played by lipocalin-2\u00a0in chronic inflammatory pain","volume":"254","author":"Jha","year":"2014","journal-title":"Exp. Neurol."},{"key":"2021113010371728400_B140","doi-asserted-by":"publisher","first-page":"e000837","DOI":"10.1161\/JAHA.114.000837","article-title":"Deamidated lipocalin-2 induces endothelial dysfunction and hypertension in dietary obese mice","volume":"3","author":"Song","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"2021113010371728400_B141","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/129\/10\/851\/447131\/cs1290851.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/129\/10\/851\/447131\/cs1290851.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T11:28:45Z","timestamp":1638271725000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/129\/10\/851\/71244\/Iron-metabolism-and-regulation-by-neutrophil"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,28]]},"references-count":141,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,11,1]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20150075","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,28]]}}}